bezafibrate has been researched along with Cirrhosis, Liver in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Abdelrahman, AM; El-Tahawy, NF; Ibrahim, SA; Mohamed, MZ | 1 |
| Ohmoto, K; Yamamoto, S; Yoshioka, N | 1 |
| Enzan, H; Ogawa, Y; Onishi, S; Saibara, T; Yoshida, S | 1 |
3 other study(ies) available for bezafibrate and Cirrhosis, Liver
| Article | Year |
|---|---|
Antifibrotic effects of bezafibrate and pioglitazone against thioacetamide-induced liver fibrosis in albino rats.
Topics: Actins; Animals; Bezafibrate; Hepatic Stellate Cells; Liver; Liver Cirrhosis; Liver Function Tests; Male; Malondialdehyde; Nitrites; Pioglitazone; Rats; Thioacetamide | 2021 |
Long-term effect of bezafibrate on parameters of hepatic fibrosis in primary biliary cirrhosis.
Topics: Administration, Oral; Adult; Aged; Bezafibrate; Female; Humans; Liver Cirrhosis; Liver Cirrhosis, Biliary; Male; Middle Aged | 2006 |
Bezafibrate for tamoxifen-induced non-alcoholic steatohepatitis.
Topics: Antineoplastic Agents, Hormonal; Bezafibrate; Breast Neoplasms; Chemotherapy, Adjuvant; Fatty Liver; Female; Humans; Hypolipidemic Agents; Liver Cirrhosis; Tamoxifen | 1999 |